Boston Scientific Corporation received CE Mark approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System featuring an ultra-thin abluminal (outer) bioabsorbable polymer coating. The SYNERGY Stent is the latest innovation in drug-eluting stent technology from Boston Scientific. It is unique in that its proprietary PLGA polymer and everolimus drug coating dissipate by three months. This innovation has the potential to improve post-implant vessel healing and will eliminate long-term polymer exposure, a possible cause of late adverse events.
Molex Incorporated will showcase the company’s MediSpec™ Micro-Miniature Coiling (MMC) capability designed for medical applications, including minimally invasive surgery, catheters and implanted devices at MD&M Minneapolis, October 30 through November 1, booth 1344. Constructed of biocompatible materials, MediSpec MMC features a continuous length coil enabling extrusion of micro gauge (50 to 26 AWG class) wire at virtually infinite lengths.
Asynt Ltd. in conjunction with Innovative Physical Organic Solutions (IPOS), a research group based within the University of Huddersfield, UK, have cooperated over the last 2 years to develop a new generation of chemical reactor.
Materials characterization company Malvern Panalytical. (Malvern Panalytical, UK) has signed an exclusive distribution agreement with Affinity Biosensors LLC (Santa Barbara, CA, USA) which will extend the range of soluti...
Bacteria’s ability to cling to virtually any surface is a vexing problem in the medical community.
Cereplast, Inc. a leading manufacturer of proprietary biobased, sustainable bioplastics, today announced that Cereplast Hybrid 651D has won the MATERIALICA Design + Technology 2012 silver award for outstanding innovation in the "Material" category. The awards ceremony took place in Munich, Germany at the 15th annual trade fair, MATERIALICA—Lightweight Design for New Mobility, on the evening of October 23, 2012.
Off to Boston: The team from the University of Freiburg has qualified for this year's finals of the "International Genetically Engineered Machine Competition" (iGEM), a science competition focusing on synthetic biology. At the European finals in Amsterdam, Netherlands, Freiburg's team also won a special prize for their research project.
Metabolix, an innovation-driven bioscience company focused on delivering sustainable solutions for plastics, chemicals and energy, today announced that new biobased PHA (polyhydroxyalkanoate) copolymers significantly improve the mechanical and environmental performance characteristics of polyvinyl chloride (PVC).
Alfa Aesar, A Johnson Matthey Company, is pleased to introduce the latest addition to its complete range of over 33,000 products. The new biochemical product catalog adds over 4,000 products to the existing offering, providing a more complete selection for a broad spectrum of research applications.
Cereplast, Inc., a leading manufacturer of proprietary biobased, sustainable bioplastics, today announced that the Company has begun selling its first Hybrid resins application in India initially for safety helmets.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.